Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington's Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits

PLoS Currents

Volumn , Issue JUL, 2013, Pages

  Kudwa, Andrea E ^a   Menalled, Liliana B ^a   Oakeshott, Stephen ^a   Murphy, Carol ^a   Mushlin, Richard ^a   Fitzpatrick, John ^a   Miller, Sam F ^a   McConnell, Kristi ^a   Port, Russell ^a   Torello, Justin ^a   Howland, David ^b   Ramboz, Sylvie ^a   Brunner, Dani ^a,c  

^a PSYCHOGENICS INC   (United States)

^b CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BEHAVIOR; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; EXPERIMENTAL MODEL; FEMALE; GENOTYPE; HUNTINGTON CHOREA; LOCOMOTION; MOUSE; NONHUMAN; OPEN FIELD TEST; REARING; ROTAROD TEST; TRANSGENIC ANIMAL;

EID: 84880952695     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.hd.0ab4f3645aff523c56ecc8ccbe41a198     Document Type: Article

References (27)

1. Bates G, Harper P and Jones L (2002) Huntington9s Disease. Third Edition. Oxford: Oxford University Press.
2. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington9s disease chromosomes. The Huntington9s Disease Collaborative Research Group. Cell. 1993 Mar 26;72(6):971-83. PubMed PMID:8458085. 8458085.
3. Heng MY, Detloff PJ, Albin RL. Rodent genetic models of Huntington disease. Neurobiol Dis. 2008 Oct;32(1):1-9. PubMed PMID:18638556. 18638556.
4. William Yang X, Gray M. Mouse Models for Validating Preclinical Candidates for Huntington's Disease 2011. PubMed PMID:21882419. 21882419.
5. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 2008 Jun 11;28(24):6182-95. PubMed PMID:18550760. 18550760.
6. Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11404-9. PubMed PMID:10500189. 10500189.
7. Menalled L, El-Khodor BF, Patry M, Suárez-Fariñas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, Signer E, Tobin A, Brunner D. Systematic behavioral evaluation of Huntington9s disease transgenic and knock-in mouse models. Neurobiol Dis. 2009 Sep;35(3):319-36. PubMed PMID:19464370. 19464370.
8. Oakeshott S, Balci F, Filippov I, Murphy C, Port R, Connor D, Paintdakhi A, Lesauter J, Menalled L, Ramboz S, Kwak S, Howland D, Silver R, Brunner D. Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington9s Disease. PLoS Curr. 2011 Apr 5;3:RRN1225. PubMed PMID:21479110. 21479110.
9. Pouladi MA, Xie Y, Skotte NH, Ehrnhoefer DE, Graham RK, Kim JE, Bissada N, Yang XW, Paganetti P, Friedlander RM, Leavitt BR, Hayden MR. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet. 2010 Apr 15;19(8):1528-38. PubMed PMID:20097678. 20097678.
10. Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR. A YAC mouse model for Huntington9s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 1999 May;23(1):181-92. PubMed PMID:10402204. 10402204.
11. Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003 Jul 1;12(13):1555-67. PubMed PMID:12812983. 12812983.
12. Van Raamsdonk JM, Murphy Z, Slow EJ, Leavitt BR, Hayden MR. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet. 2005 Dec 15;14(24):3823-35. PubMed PMID:16278236. 16278236.
13. Van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, Leavitt BR, Hayden MR. Body weight is modulated by levels of full-length huntingtin. Hum Mol Genet. 2006 May 1;15(9):1513-23. PubMed PMID:16571604. 16571604.
14. Graham RK, Slow EJ, Deng Y, Bissada N, Lu G, Pearson J, Shehadeh J, Leavitt BR, Raymond LA, Hayden MR. Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol Dis. 2006 Feb;21(2):444-55. PubMed PMID:16230019. 16230019.
15. Callahan JW, Abercrombie ED. In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington9s Disease. Front Syst Neurosci. 2011;5:61. PubMed PMID:21811446. 21811446.
16. Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, Jones L, Dunnett SB. Selective cognitive impairment in the YAC128 Huntington9s disease mouse. Brain Res Bull. 2012 Jun 1;88(2-3):121-9. PubMed PMID:21624441. 21624441.
17. McFadyen MP, Kusek G, Bolivar VJ, Flaherty L. Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod. Genes Brain Behav. 2003 Aug;2(4):214-9. PubMed PMID:12953787. 12953787.
18. Gil-Mohapel JM. Screening of therapeutic strategies for Huntington9s disease in YAC128 transgenic mice. CNS Neurosci Ther. 2012 Jan;18(1):77-86. PubMed PMID:21501423. 21501423.
19. Carroll JB, Southwell AL, Graham RK, Lerch JP, Ehrnhoefer DE, Cao LP, Zhang WN, Deng Y, Bissada N, Henkelman RM, Hayden MR. Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease. Mol Neurodegener. 2011 Aug 19;6:59. PubMed PMID:21854568. 21854568.
20. Chen X, Wu J, Luo Y, Liang X, Supnet C, Kim MW, Lotz GP, Yang G, Muchowski PJ, Kodadek T, Bezprozvanny I. Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington9s disease. Chem Biol. 2011 Sep 23;18(9):1113-25. PubMed PMID:21944750. 21944750.
21. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington9s disease. Behav Brain Res. 2010 Dec 25;214(2):193-200. PubMed PMID:20493905. 20493905.
22. Singer J. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. Journal of Educational and Behavioral Statistics, Vol. 23, No. 4 (Winter, 1998), pp. 323-355.
23. Fahlström A, Zeberg H, Ulfhake B. Changes in behaviors of male C57BL/6J mice across adult life span and effects of dietary restriction. Age (Dordr). 2012 Dec;34(6):1435-52. PubMed PMID:21989972. 21989972.
24. Ingram DK, Weindruch R, Spangler EL, Freeman JR, Walford RL. Dietary restriction benefits learning and motor performance of aged mice. J Gerontol. 1987 Jan;42(1):78-81. PubMed PMID:3794202. 3794202.
25. Stewart J, Mitchell J, Kalant N. The effects of life-long food restriction on spatial memory in young and aged Fischer 344 rats measured in the eight-arm radial and the Morris water mazes. Neurobiol Aging. 1989 Nov-Dec;10(6):669-75. PubMed PMID:2628778. 2628778.
26. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet. 1999 Mar;8(3):397-407. PubMed PMID:9949199. 9949199.
27. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2911-6. PubMed PMID:12589027. 12589027.